On the 22 dec this was a ASX announcement but hey dyorThe...

On the 22 dec this was a ASX announcement but hey dyor

The company is currently working with existing partners to incorporate ResAppDx as an App Clip or Instant App into current offerings.
The company has also added functionality which allows ResAppDx to detect COPD. COPD is a chronic lung disease, characterised by long-term breathing problems and poor airflow due to airway obstruction. Main symptoms include shortness of breath and cough with sputum production.
It is a progressive disease, typically worsening over time. COPD accounts for approximately 3m deaths globally per year and is the fourth leading cause of death. It impacts over 384m people worldwide and it is estimated that 80% of people with COPD are undiagnosed.


Importantly, ResAppDx 2.3 now supports App Clip (on iOS) and Instant App (on Android) functionality. App Clip and Instant App software was introduced to allow users to experience or utilise a specific part of a smartphone application, without downloading it entirely to a device.Instead of installing the ResAppDx app to undertake a respiratory diagnostic test, users can now access ResAppDx instantly through a website link, QR code or text message received from a clinician or telehealth provider. Test results will then be sent directly to the clinician for review. This is a major development for ResApp and will allow for enhanced integration of ResAppDx with new and existing partners.